CVS Health Corporation (CVS)
NYSE: CVS · IEX Real-Time Price · USD
67.18
-0.15 (-0.22%)
At close: Apr 26, 2024, 4:00 PM
67.24
+0.06 (0.09%)
After-hours: Apr 26, 2024, 7:59 PM EDT

CVS Health Revenue

In the year 2023, CVS Health had annual revenue of $357.78B with 10.95% growth. Revenue in the quarter ending December 31, 2023 was $93.81B with 11.89% year-over-year growth.

Revenue (ttm)
$357.78B
Revenue Growth
+10.95%
P/S Ratio
0.24
Revenue / Employee
$1,192,587
Employees
300,000
Market Cap
84.54B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023357.78B35.31B10.95%
Dec 31, 2022322.47B30.36B10.39%
Dec 31, 2021292.11B23.41B8.71%
Dec 31, 2020268.71B11.93B4.65%
Dec 31, 2019256.78B62.20B31.96%
Dec 31, 2018194.58B9.79B5.30%
Dec 31, 2017184.79B7.24B4.08%
Dec 31, 2016177.55B24.26B15.82%
Dec 31, 2015153.29B13.92B9.99%
Dec 31, 2014139.37B12.61B9.94%
Dec 31, 2013126.76B3.64B2.96%
Dec 31, 2012123.12B16.04B14.98%
Dec 31, 2011107.08B11.30B11.80%
Dec 31, 201095.78B-2.44B-2.48%
Dec 31, 200998.22B10.74B12.28%
Dec 31, 200887.47B11.14B14.60%
Dec 29, 200776.33B32.51B74.18%
Dec 30, 200643.82B6.81B18.41%
Dec 31, 200537.01B6.41B20.96%
Jan 1, 200530.59B4.01B15.07%
Jan 3, 200426.59B2.41B9.95%
Dec 28, 200224.18B1.94B8.72%
Dec 29, 200122.24B2.15B10.72%
Dec 30, 200020.09B1.99B10.99%
Jan 1, 200018.10B2.82B18.49%
Dec 31, 199815.27B1.52B11.08%
Dec 31, 199713.75B1.92B16.21%
Dec 31, 199611.83B2.07B21.18%
Dec 31, 19959.76B5.43B125.48%
Dec 31, 19944.33B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
McKesson 301.51B
Cigna 195.27B
HCA Healthcare 64.97B
Bristol-Myers Squibb Company 45.53B
GSK 38.39B
Medtronic 32.32B
Gilead Sciences 27.12B
Regeneron Pharmaceuticals 13.12B
Revenue Rankings